Kit ELISA CHI3L1/YKL-40 sandwich (human): quantitative determination of Hu CHI3L1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CHI3L1.
Accession number
P36222
Dose range
6.14-1500 pg/ml
Sensitivity of the dosage
6 pg/ml
Calibration range
6 pg/ml to 1.500 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA CHI3L1/YKL-40 sandwich (human): quantitative determination of Hu CHI3L1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CHI3L1.
Kit ELISA CHI3L1/YKL-40 sandwich (human): quantitative determination of Hu CHI3L1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu CHI3L1.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The human cartilage glycoprotein 39 (GP-39), also known as YKL-40, is a glycoprotein secreted by joint chondrocytes, synoviocytes, and macrophages. GP-39 levels in serum and synovial fluid are high in inflammatory diseases and correlated with the degree of joint destruction in rheumatoid arthritis. GP-39 is expressed in joint and synovial chondrocytes and in the liver, but is undetectable in muscle tissue, lungs, pancreas, mononuclear cells and fibroblasts. GP-39 is a self-antigen candidate in rheumatoid arthritis and is important for the ability of cells to respond and cope with changes in their environment.